首页 > 市场调查报告书 > 通讯

市场调查报告书

商品编码

1477199

功能服务提供者市场，按服务类型、按阶段、按治疗领域、按最终用户、按地理位置

Functional Service Providers Market, By Service Type, By Stage, By Therapeutic Area, By End User, By Geography

出版日期: 2024年04月01日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

功能服务供应商（FSP）市场预计 2024 年价值为 169.4 亿美元，预计到 2031 年将达到 298.1 亿美元，2024 年至 2031 年年复合成长率（CAGR）为 8.4%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	169.4 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	8.40%	2031 年价值预测：	298.1 亿美元

图 1. 功能服务提供者 (FSP) 市场占有率 (%)（按地区），2024 年

功能服务提供者 (FSP) 旨在代表组织管理不同的后端和管理功能，使他们能够专注于核心业务活动。他们处理非核心但关键的业务职能，例如财务和会计、人力资源管理、采购和供应链管理等。这使得客户组织能够有效地扩展其营运成本，而无需投资开发广泛的内部功能。它们有助于提高营运效率并优化成本。市场为企业提供了利用专业知识和技术来改进各种功能流程的机会。

市场动态：

功能服务提供者市场的成长是由于越来越多地采用外包作为降低营运成本和获得专业领域专业知识的策略而推动的。许多组织希望与 FSP 合作，根据不断变化的业务需求灵活扩展其营运。市场对某些职能失去控制的担忧以及关键活动过度依赖外部合作伙伴带来的风险感到克制。然而，自动化技术的进步和创新商业模式的出现等因素正在该领域创造新的机会。供应商正在利用分析、人工智慧和区块链等技术开发行业和特定功能的解决方案。例如，2022 年 9 月，区块链整合电子临床平台供应商 Triall 与 Mayo Clinic 研究人员合作，推动临床试验设计和资料管理技术。此次合作代表着引导全球转型为分散式临床研究的重要一步。

研究的主要特点：

该报告对全球功能服务提供者（FSP）市场进行了深入分析，并提供了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），考虑到2023年为基准年。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球功能服务提供者（FSP）市场的主要参与者。
本研究涵盖的主要公司包括 IQVIA、Parexel International Corporation、ICON plc、PRA Health Sciences、Covance Inc.、Charles River Laboratories International Inc.、Syneos Health、Pharmaceutical Product Development LLC (PPD)、Medpace Holdings Inc.。药明康德、埃森哲、Cognizant、Quanticate 和BioPoint Inc.
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球功能服务提供者（FSP）市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球功能服务提供者（FSP）市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东协
亚太其他地区
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
南非
北非
中非

第 9 章：公司简介 - 全球功能服务供应商 (FSP) 市场

IQVIA
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
Parexel International Corporation
ICON plc
PRA Health Sciences
Covance Inc.
Charles River Laboratories International Inc.
Syneos Health
Pharmaceutical Product Development LLC (PPD)
Medpace Holdings Inc.
LabCorp
Wuxi AppTec
Accenture
Cognizant
Quanticate
BioPoint Inc.

第 10 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI5962

The functional service providers (FSP) market is estimated to be valued at USD 16.94 Bn in 2024 and is expected to reach USD 29.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.94 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.40%	2031 Value Projection:	US$ 29.81 Bn

Figure 1.Functional Service Providers (FSP) Market Share (%), By Region, 2024

Functional Service Providers Market - IMG1

Functional service providers (FSPs) aim to manage different back-end and administrative functions on behalf of organizations enabling them to focus on their core business activities. They handle non-core but critical business functions such as finance and accounting, human resource management, procurement, and supply chain management among others. This allows client organizations to scale their operations cost effectively without having to invest in developing extensive in-house functional capabilities. They help improve operational efficiency and optimize costs. The market provides opportunities for enterprises to leverage specialized expertise and technologies for improving various functional processes.

Market Dynamics:

The growth of the functional service providers market growth is driven by the increasing adoption of outsourcing as a strategy for reducing operational costs and gaining access to specialized domain expertise. Many organizations look to work with FSPs to scale their operations flexibly according to changing business needs. The market sees restraints from concerns around loss of control over certain functions and risks related to over-dependence on external partners for critical activities. However, factors such as advancements in automation technologies and emergence of innovative business models are creating new opportunities in this space. Vendors are developing industry and function-specific solutions leveraging technologies like analytics, AI and blockchain. For instance, in September 2022, Triall, a blockchain-integrated eClinical platform provider, collaborated with Mayo Clinic researchers to advance clinical trial design and data management techniques. This collaboration represents an essential step forward in guiding a global transformation toward decentralized clinical research.

Key Features of the Study:

This report provides an in-depth analysis of the global functional service providers (FSP) market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global functional service providers (FSP) market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include IQVIA, Parexel International Corporation, ICON plc, PRA Health Sciences, Covance Inc., Charles River Laboratories International Inc., Syneos Health, Pharmaceutical Product Development LLC (PPD), Medpace Holdings Inc., LabCorp, Wuxi AppTec, Accenture, Cognizant, Quanticate, and BioPoint Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global functional service providers (FSP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global functional service providers (FSP) market.

Detailed Segmentation:

Service Type:
- Clinical Trail Design and Monitoring
- Regulatory Affairs
- Data Management
- Pharmacovigilance and Drug Safety
- Biostatistics/Programming
- Medical Writing
- Others
Stage:
- Clinical Development
- Post Approval
Therapeutic Area:
- Oncology
- Cardiovascular
- Infectious Diseases
- Central Nervous System (CNS)
- Respiratory
- Immunology
- Gastrointestinal
- Others
End User:
- Biopharmaceutical Companies
- Medical Device Companies
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- IQVIA
- Parexel International Corporation
- ICON plc
- PRA Health Sciences
- Covance Inc.
- Charles River Laboratories International Inc.
- Syneos Health
- Pharmaceutical Product Development LLC (PPD)
- Medpace Holdings Inc.
- LabCorp
- Wuxi AppTec
- Accenture
- Cognizant
- Quanticate
- BioPoint Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Stage
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending by Country

4. Global Functional Service Providers (FSP) Market, By Service Type, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Clinical Trial Design and Monitoring, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Regulatory Affairs, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Data Management, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Pharmacovigilance and Drug Safety, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Biostatistics/Programming, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Medical Writing, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Others, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

5. Global Functional Service Providers (FSP) Market, By Stage, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Clinical Development, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Post Approval, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

6. Global Functional Service Providers (FSP) Market, By Therapeutic Area, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Oncology, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Cardiovascular, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Infectious Diseases, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Central Nervous System (CNS), 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Respiratory, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Immunology, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Gastrointestinal, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Others, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

7. Global Functional Service Providers (FSP) Market, By End User, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Biopharmaceutical Companies, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Medical Device Companies, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Others, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

8. Global Functional Service Providers (FSP) Market, By Region, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (USD BN)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (USD BN)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
China
India
Japan
Australia
South Korea
ASEAN
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest Of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
South Africa
North Africa
Central Africa

9. Company Profiles - Global Functional Service Providers (FSP) Market

IQVIA
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Parexel International Corporation
ICON plc
PRA Health Sciences
Covance Inc.
Charles River Laboratories International Inc.
Syneos Health
Pharmaceutical Product Development LLC (PPD)
Medpace Holdings Inc.
LabCorp
Wuxi AppTec
Accenture
Cognizant
Quanticate
BioPoint Inc.